{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:13:14Z","timestamp":1769580794296,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"St. Paul\u2019s Hospital Chair in Substance Use Research"},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010658","name":"St. Paul's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012453","name":"Providence Health Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institutes of Drug Abuse","doi-asserted-by":"crossref","award":["U01DA0251525"],"award-info":[{"award-number":["U01DA0251525"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NG Biomed, Ltd"},{"name":"Canopy Growth"},{"name":"Government of British Columbia's Ministry of Mental Health and Addictions."},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["017542 CIHR 2020"],"award-info":[{"award-number":["017542 CIHR 2020"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The overdose crisis in Canada has worsened since the emergence of the COVID-19 pandemic. Although this trend is thought to be driven in part by closures or reduced capacity of supervised consumption services (SCS), little is known about the factors that may impede access to such services during the COVID-19 pandemic among people who use drugs. This study sought to characterize the prevalence and correlates of having difficulty accessing SCS during the COVID-19 pandemic among people who use drugs in Vancouver, Canada.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cross-sectional data from two open prospective cohorts of people who use drugs were collected via phone or videoconferencing interviews conducted between July 2020 and November 2020. Multivariable logistic regression analyses were used to examine factors associated with experiencing difficulty accessing SCS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 428 people who use drugs who participated in the study, 223 (54.7%) self-identified as men and the median age was 51\u00a0years (1st to 3rd quartile: 42\u201358). A total of 58 (13.6%) participants reported experiencing difficulty accessing SCS. In a multivariable analysis, factors positively associated with difficulty accessing SCS included daily crystal methamphetamine use (Adjusted odds ratio [AOR]\u2009=\u20092.60; 95% confidence interval [CI] 1.28\u20135.30), active injection drug use (AOR\u2009=\u20094.06; 95% CI 1.38\u201311.90), recent non-fatal overdose (AOR\u2009=\u20092.45; 95% CI 1.24\u20134.85), and unstable housing (AOR\u2009=\u20092.14; 95% CI 1.08\u20134.23). Age was inversely associated with the outcome (AOR\u2009=\u20090.96; 95% CI 0.93\u20130.99) in multivariable analyses. The most commonly reported reasons for experiencing difficulty accessing SCS were: COVID-19-related site closure or shortened hours (42.9%) and having to wait too long to use a site (39.3%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found that people who use drugs with markers of structural vulnerability and drug-related risk were more likely to experience difficulty accessing SCS during the COVID-19 pandemic. These findings point to the need for strategies to support access to such services as part of pandemic response efforts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00712-7","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T19:03:43Z","timestamp":1668798223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada"],"prefix":"10.1186","volume":"19","author":[{"given":"Rachel","family":"Cassie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zishan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Strike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Clare","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"712_CR1","unstructured":"Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics [Internet]. 2022 [cited 2022 Feb 28]; Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"712_CR2","unstructured":"Opioid- and Stimulant-related Harms in Canada. Public Health Agency of Canada [Internet]. 2021 [cited 2022 Feb 28]; Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants"},{"key":"712_CR3","unstructured":"How the Province is Responding. Government of BC [Internet]. 2018 [cited 2022 Feb 28]; Available from: https:\/\/www2.gov.bc.ca\/gov\/content\/overdose\/how-the-province-is-responding"},{"key":"712_CR4","unstructured":"BC Coroners Service. Illicit Drug Toxicity Deaths in BC [Internet]. Victoria; 2021 [cited 2022 Feb 28]; Available from: https:\/\/www2.gov.bc.ca\/assets\/gov\/birth-adoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/illicit-drug.pdf"},{"key":"712_CR5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, Milloy M-J, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377:1429\u201337.","journal-title":"Lancet"},{"key":"712_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: What has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368.","journal-title":"Drug Alcohol Depend"},{"key":"712_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugpo.2019.01.017","volume":"66","author":"B Wallace","year":"2019","unstructured":"Wallace B, Pagan F, Pauly BB. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. Int J Drug Policy. 2019;66:64\u201372.","journal-title":"Int J Drug Policy"},{"key":"712_CR8","unstructured":"Supervised consumption sites and services: Explained. Health Canada [Internet]. 2021 [cited 2022 Feb 28]; Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/supervised-consumption-sites\/explained.html"},{"key":"712_CR9","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1056\/NEJMc052939","volume":"354","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Zhang R, Stoltz J-A, Lai C, Montaner JSG, et al. Attendance at supervised injecting facilities and use of detoxification services. New Engl J Med. 2006;354:2512\u20134.","journal-title":"New Engl J Med"},{"key":"712_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","volume":"14","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV\/AIDS Rep. 2017;14:161\u201383.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"712_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","volume":"366","author":"T Kerr","year":"2005","unstructured":"Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366:316\u20138.","journal-title":"Lancet"},{"key":"712_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/pubmed\/fdl090","volume":"29","author":"J-A Stoltz","year":"2007","unstructured":"Stoltz J-A, Wood E, Small W, Li K, Tyndall M, Montaner J, et al. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health. 2007;29:35\u20139.","journal-title":"J Public Health"},{"key":"712_CR13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","volume":"102","author":"E Wood","year":"2007","unstructured":"Wood E, Tyndall MW, Zhang R, Montaner JSG, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007;102:916\u20139.","journal-title":"Addiction"},{"key":"712_CR14","unstructured":"Supervised consumption sites: Status of applications [Internet]. Government of Canada; 2021 Jul. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/supervised-consumption-sites\/status-application.html"},{"key":"712_CR15","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/add.14417","volume":"113","author":"J Boyd","year":"2018","unstructured":"Boyd J, Collins A, Mayer S, Maher L, Kerr T, McNeil R. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada. Addiction. 2018;113:2261\u201370.","journal-title":"Addiction"},{"key":"712_CR16","doi-asserted-by":"publisher","first-page":"102967","DOI":"10.1016\/j.drugpo.2020.102967","volume":"86","author":"MC Kennedy","year":"2020","unstructured":"Kennedy MC, Hayashi K, Holiday E, Wood E, Kerr T. Assisted injection within supervised injection services: uptake and client characteristics among people who require help injecting in a Canadian setting. Int J Drug Policy. 2020;86:102967.","journal-title":"Int J Drug Policy"},{"key":"712_CR17","unstructured":"Overdose Prevention Sites and Supervised Consumption Sites: [Internet]. Vancouver Coastal Health; 2021 [cited 2021 Oct 28]. Available from: http:\/\/www.vch.ca\/Documents\/VCH-overdose-alert.pdf"},{"key":"712_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.102641","volume":"76","author":"AB Collins","year":"2020","unstructured":"Collins AB, Boyd J, Hayashi K, Cooper HLF, Goldenberg S, McNeil R. Women\u2019s utilization of housing-based overdose prevention sites in Vancouver, Canada: an ethnographic study. Int J Drug Policy. 2020;76: 102641.","journal-title":"Int J Drug Policy"},{"key":"712_CR19","unstructured":"Response to the Opioid Overdose Crisis in Vancouver Coastal Health [Internet]. Vancouver Coastal Health; 2018. Available from: http:\/\/www.vch.ca\/Documents\/CMHO-report.pdf"},{"key":"712_CR20","unstructured":"Housing Overdose Prevention Site Manual 2018 [Internet]. Vancouver Coastal Health; 2018. Available from: http:\/\/www.vch.ca\/Documents\/Housing-overdose-revention-site-HOPS-Manual.pdf"},{"key":"712_CR21","unstructured":"Modelling opioid-related deaths during the COVID-19 outbreak. Public Health Agency of Canada [Internet]. 2021 [cited 2022 Feb 28]; Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/data-surveillance-research\/modelling-opioid-overdose-deaths-covid-19.html"},{"key":"712_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.15288\/jsad.2020.81.556","volume":"81","author":"M Bonn","year":"2020","unstructured":"Bonn M, Palayew A, Bartlett S, Brothers TD, Touesnard N, Tyndall M. Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply. J Stud Alcohol Drugs. 2020;81:556\u201360.","journal-title":"J Stud Alcohol Drugs"},{"key":"712_CR23","unstructured":"Me A, Zeiler I, Garcia Yi J. COVID-19 and the drug supply chain: from production and trafficking to use [Internet]. Vienna: United Nations Office on Drugs and Crime; 2020. Available from: https:\/\/www.unodc.org\/documents\/data-and-analysis\/covid\/Covid-19-and-drug-supply-chain-Mai2020.pdf"},{"key":"712_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109471","volume":"236","author":"E McAdam","year":"2022","unstructured":"McAdam E, Hayashi K, Dong H, Cui Z, Sedgemore K, Dietze P, et al. Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: evidence from community-recruited cohorts of people who use drugs in Vancouver, Canada. Drug Alcohol Depend. 2022;236: 109471.","journal-title":"Drug Alcohol Depend"},{"key":"712_CR25","unstructured":"Changes Related to COVID-19 in the Illegal Drug Supply and Access to Services, and Resulting Health Harms [Internet]. Canadian Centre on Substance Use and Addiction; 2020 May. Available from: https:\/\/www.ccsa.ca\/sites\/default\/files\/2020-05\/CCSA-COVID-19-CCENDU-Illegal-Drug-Supply-Alert-2020-en.pdf"},{"key":"712_CR26","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.14664","volume":"114","author":"M Irvine","year":"2019","unstructured":"Irvine M, Kuo M, Buxton J, Balshaw R, Otterstatter M, Macdougall L, et al. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction. 2019;114:1602\u201313.","journal-title":"Addiction"},{"key":"712_CR27","unstructured":"Office of the Provincial Health Officer. Responding to British Columbia\u2019s Public Health Emergency; Progress Update January to June 2020 [Internet]. Victoria; 2020. Available from: https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/about-bc-s-health-care-system\/office-of-the-provincial-health-officer\/overdose-response-progress-update-jan-july-2020.pdf"},{"key":"712_CR28","unstructured":"Kieltyka M. Inner-City COVID-19 Response Strategy based on three pillars: Prevent, Test and Trace, Support [Internet]. Vancouver: Vancouver Coastal Health; 2020 Apr. Available from: http:\/\/www.vch.ca\/about-us\/news\/news-releases\/inner-city-covid-19-response-strategy-based-on-three-pillars-prevent-test-and-trace-support"},{"key":"712_CR29","unstructured":"Drug situation in Vancouver [Internet]. Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV\/AIDS; 2013 Jun. Available from: https:\/\/www.bccsu.ca\/wp-content\/uploads\/2016\/08\/dsiv2013.pdf"},{"key":"712_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jhm.2344","volume":"10","author":"L Ti","year":"2015","unstructured":"Ti L, Buxton J, Harrison S, Dobrer S, Montaner J, Wood E, et al. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs. J Hosp Med. 2015;10:301\u20136.","journal-title":"J Hosp Med"},{"key":"712_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.amepre.2019.04.024","volume":"57","author":"MC Kennedy","year":"2019","unstructured":"Kennedy MC, Klassen DC, Dong H, Milloy M-JS, Hayashi K, Kerr TH. Supervised injection facility utilization patterns: a prospective cohort study in Vancouver, Canada. Am J Prev Med. 2019;57:330\u20137.","journal-title":"Am J Prev Med"},{"key":"712_CR32","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1097\/ADM.0000000000000646","volume":"14","author":"S Ickowicz","year":"2020","unstructured":"Ickowicz S, Grant C, Nosova E, Boyd J, Brar R, Milloy M-J, et al. Factors associated with the use of supervised consumption facilities among women who inject drugs in a Canadian setting. J Addict Med. 2020;14:e226.","journal-title":"J Addict Med"},{"key":"712_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.healthplace.2006.05.005","volume":"13","author":"B Maas","year":"2007","unstructured":"Maas B, Fairbairn N, Kerr T, Li K, Montaner JSG, Wood E. Neighborhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007;13:432\u20139.","journal-title":"Health Place"},{"key":"712_CR34","doi-asserted-by":"crossref","unstructured":"Ivsins A, Vancouver Area Network of Drug Users of, Benoit C, Kobayashi K, Boyd S. From risky places to safe spaces: re-assembling spaces and places in Vancouver\u2019s Downtown Eastside. Health & Place. 2019;59","DOI":"10.1016\/j.healthplace.2019.102164"},{"key":"712_CR35","unstructured":"Bouchard M, Macdonald M, Ponce C, Milloy M-J, Hayashi K, DeBeck K. Estimating the size of the fentanyl market in British Columbia. Vancouver, BC: Cullen Commission; 2020 Oct."},{"key":"712_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1471-2458-9-270","volume":"9","author":"C Kim","year":"2009","unstructured":"Kim C, Kerr T, Li K, Zhang R, Tyndall MW, Montaner JS, et al. Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting. BMC Public Health. 2009;9:270.","journal-title":"BMC Public Health"},{"key":"712_CR37","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1097\/QAD.0b013e328315cdd3","volume":"22","author":"V Lima","year":"2008","unstructured":"Lima V, Harrigan R, Murray M, Moore D, Wood E, Hogg R, et al. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS. 2008;22:2371\u201380.","journal-title":"AIDS"},{"key":"712_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.amepre.2005.04.011","volume":"29","author":"E Wood","year":"2005","unstructured":"Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JSG, et al. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29:126\u201330.","journal-title":"Am J Prev Med"},{"key":"712_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.annemergmed.2019.07.014","volume":"75","author":"N Krawczyk","year":"2020","unstructured":"Krawczyk N, Eisenberg M, Schneider KE, Richards TM, Lyons BC, Jackson K, et al. Predictors of overdose death among high-risk emergency department patients with substance-related encounters: a data linkage cohort study. Ann Emerg Med. 2020;75:1\u201312.","journal-title":"Ann Emerg Med"},{"key":"712_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","volume":"162","author":"A Caudarella","year":"2016","unstructured":"Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"712_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/13698575.2012.680950","volume":"14","author":"W Small","year":"2012","unstructured":"Small W, Moore D, Shoveller J, Wood E, Kerr T. Perceptions of risk and safety within injection settings: injection drug users\u2019 reasons for attending a supervised injecting facility in Vancouver, Canada. Health Risk Soc. 2012;14:307\u201324.","journal-title":"Health Risk Soc"},{"key":"712_CR42","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/1049732311400919","volume":"21","author":"W Small","year":"2011","unstructured":"Small W, Shoveller J, Moore D, Tyndall M, Wood E, Kerr T. Injection drug users\u2019 access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Qual Health Res. 2011;21:743\u201356.","journal-title":"Qual Health Res"},{"key":"712_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/00952990601175102","volume":"33","author":"I McKnight","year":"2007","unstructured":"McKnight I, Maas B, Wood E, Tyndall MW, Small W, Lai C, et al. Factors associated with public injecting among users of Vancouver\u2019s supervised injection facility. Am J Drug Alcohol Abuse. 2007;33:319\u201325.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"712_CR44","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.addbeh.2006.07.013","volume":"32","author":"S Petrar","year":"2007","unstructured":"Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JSG, Wood E. Injection drug users\u2019 perceptions regarding use of a medically supervised safer injecting facility. Addict Behav. 2007;32:1088\u201393.","journal-title":"Addict Behav"},{"key":"712_CR45","unstructured":"Office of the Provincial Health Officer. Responding to British Columbia\u2019s Public Health Emergency; Progress Update January to June 2021 [Internet]. Victoria; 2021. Available from: https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/about-bc-s-health-care-system\/office-of-the-provincial-health-officer\/overdose-response-progress-update-jan-july-2021.pdf"},{"key":"712_CR46","unstructured":"Jones RP. Injection site scales back physical distancing rules to prevent ODs. CBC News [Internet]. Ottawa; 2020 [cited 2022 Feb 28]; Available from: https:\/\/www.cbc.ca\/news\/canada\/ottawa\/byward-market-supervised-injection-site-lifts-physical-distancing-1.5566985"},{"key":"712_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0154-1","volume":"14","author":"T Kerr","year":"2017","unstructured":"Kerr T, Mitra S, Kennedy MC, McNeil R. Supervised injection facilities in Canada: past, present, and future. Harm Reduct J. 2017;14:1\u20139.","journal-title":"Harm Reduct J"},{"key":"712_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.socscimed.2019.02.014","volume":"225","author":"MC Kennedy","year":"2019","unstructured":"Kennedy MC, Boyd J, Mayer S, Collins A, Kerr T, McNeil R. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada. Soc Sci Med. 2019;225:60\u20138.","journal-title":"Soc Sci Med"},{"key":"712_CR49","unstructured":"COVID-19: Provincial Episodic Overdose Prevention Service (e-OPS) Protocol [Internet]. Vancouver; 2020 May. Available from: http:\/\/www.bccdc.ca\/Health-Professionals-Site\/Documents\/COVID19_EpisodicOPSProtocolGuidelines.pdf"},{"key":"712_CR50","unstructured":"Office of the Provincial Health Officer. Responding to British Columbia\u2019s Public Health Emergency; Progress Update August to December 2020 [Internet]. Victoria; 2021. Available from: https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/about-bc-s-health-care-system\/office-of-the-provincial-health-officer\/overdose-response-progress-update-aug-dec-2020.pdf"},{"key":"712_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3109\/10826084.2012.644107","volume":"47","author":"W Small","year":"2012","unstructured":"Small W, Wood E, Tobin D, Rikley J, Lapushinsky D, Kerr T. The injection support team: a peer-driven program to address unsafe injecting in a Canadian setting. Subst Use Misuse. 2012;47:491\u2013501.","journal-title":"Subst Use Misuse"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00712-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00712-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00712-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T19:10:48Z","timestamp":1668798648000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00712-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00712-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent for study participation. The cohort studies have been approved by the University of British Columba\/Providence Health Care Research Ethics Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MJ Milloy\u2019s institution has received an unstructured gift to support his research from NG Biomed, Ltd, an applicant to the Canadian federal government for a license to produce medical cannabis. He is the Canopy Growth Professor of cannabis science at the University of British Columbia, a position created by an unstructured gift to the university from Canopy Growth, a licensed producer of cannabis, and the Government of British Columbia\u2019s Ministry of Mental Health and Addictions. Kanna Hayashi has an unpaid appointment as a member of the Scientific and Research Staff at the Department of Family and Community Practice of the Vancouver Coastal Health (VCH) Authority, which runs supervised injection services that were examined in the present study. Jeff West is a Manager of Harm Reduction and Substance Use Services at VCH. However, neither the health authority nor the aforementioned funders had a role in the study design; collection, analysis and interpretation of data; writing of the paper; or decision to submit for publication. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}